SBIR & STTR

SBIR/STTR program updates, proposal strategy, commercialization plans, and reauthorization news.

85 articles

SBIR/STTR Came Back After a Six-Month Lapse, but the Rules Changed. The New $30M Strategic Breakthrough Award and FY 2027 Proposal Caps Will Restructure How Small Businesses Compete.

S. 3971 — the Small Business Innovation and Economic Security Act — reauthorized SBIR and STTR through September 30, 2031 after a six-month lapse. The legislation adds Strategic Breakthrough Awards up to $30M with 100% matching, eight-watchlist foreign-affiliation screening, and FY 2027 per-company proposal caps. Companies that built their pipeline around volume submissions need a new strategy now.

May 25, 2026Arthur Griffin
DARPA's Biological Technologies Office Just Pre-Released Four FY26 SBIR Topics — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Why the Direct-to-Phase-II Slots Are the Real Story.

DARPA BTO pre-released four FY26 SBIR/STTR topics on April 30, 2026, with proposals due June 3. Two topics — SWiFT and EXPOSITION — offer Direct-to-Phase-II awards up to $1.5M, bypassing the standard Phase I gate. Here is what each topic is actually solving, why the DP2 structure matters, and how small biotech, surgical robotics, and battlefield-medicine teams should decide whether to compete.

May 19, 2026Arthur Griffin
SBIR/STTR Is Reauthorized Through 2031. The New $30 Million Strategic Breakthrough Award, Proposal Caps, and Foreign-Risk Screening Rewrite the Playing Field — Here Is What Changes Now.

On April 13, 2026, President signed S. 3971 reauthorizing SBIR/STTR through September 30, 2031 — the longest extension in program history. The new law introduces $30M Strategic Breakthrough Awards, FY2027 proposal caps to address SBIR mills, expanded foreign-risk screening, and stronger TABA support. Here is how small businesses, university spinouts, and dual-use startups should reposition for the next two solicitation cycles.

May 19, 2026Claire Cummings
NASA's SBIR/STTR BAA Transition: The Structural Shift From Annual Solicitations to Phased Appendices, the May 21 Appendix A/B Deadline, and What It Means for Small Businesses Through September 2027

NASA released a Broad Agency Announcement on April 17, 2026, that replaces the agency's traditional annual SBIR/STTR solicitation cycle with a phased-appendix model valid through September 30, 2027. Appendix A and Appendix B opened April 21 with a May 21 deadline; additional appendices will release throughout the BAA period. The shift breaks the once-a-year proposal cadence small businesses have planned around since the program's founding and demands a different operational posture.

May 17, 2026Jared Klein
DARPA's June 3 Quadruple: Four BTO SBIRs That Sketch the Future of Distributed Battlefield Medicine

On June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.

May 13, 2026Arthur Griffin
SBIR's $30 Million Strategic Breakthrough Awards Aren't a New Grant. They're the End of SBIR as Pure Research Funding.

The Strategic Breakthrough Awards mechanism authorized in the February 2026 SBIR reauthorization is the first post-Phase II funding instrument in program history. The mandatory 100 percent private match and the four-year performance window reposition SBIR from research subsidy to commercialization accelerator — and small businesses that do not understand that pivot will fail to compete for the first solicitations in Q4.

May 13, 2026Arthur Griffin
DOE SBIR Topics for Clean Energy Startups

The Department of Energy funds SBIR proposals in clean energy, grid modernization, advanced materials, and nuclear technology. Here are the topic areas to watch after reauthorization.

Mar 4, 2026Jared Klein
SBIR for Biotech Startups: NIH Phase I Strategy

Biotech startups can access up to $275K in non-dilutive NIH SBIR funding for early-stage drug development, diagnostics, and medical devices. Here is how to build a winning Phase I proposal.

Mar 4, 2026Claire Cummings
SBIR Direct to Phase II: When to Skip Phase I

Some agencies allow companies to apply directly to Phase II without a Phase I award. Here is how Direct to Phase II works, who qualifies, and when it makes strategic sense.

Mar 4, 2026Arthur Griffin
SBIR Subcontracting Rules: The 33% Rule Explained

SBIR requires your company to perform at least two-thirds of Phase I work. Here is how the subcontracting rules work, how to calculate work percentages, and what happens when you exceed the limit.

Mar 4, 2026Arthur Griffin
SBIR vs. STTR: Which Program Should You Apply To?

SBIR and STTR fund the same types of innovation but have different rules for university partnerships and work percentages. Here is how to choose the right program for your company.

Mar 4, 2026Arthur Griffin

Frequently Asked Questions

What SBIR topics are covered?

We cover Phase I and Phase II proposals, commercialization plans, agency-specific guidance (NIH, NSF, DOD, DOE, NASA), reauthorization updates, and proposal cap changes.

Is STTR also covered?

Yes. STTR articles cover university-industry partnerships, IP agreements, work-split requirements, and when to choose STTR over SBIR.

Get SBIR & STTR Updates Weekly

New articles, deadline alerts, and funding tips every Tuesday.

Not sure which grants to apply for?

Use our free grant finder to search active federal funding opportunities by agency, eligibility, and deadline.

Find Grants